A third-generation herpesvirus is effective against gastroesophageal cancer

Journal of Surgical Research

Volumn 163, Issue 2, 2010, Pages 214-220

  Wong, Joyce ^a   Kelly, Kaitlyn ^a   Mittra, Arjun ^a   Gonzalez, Segundo Jaime ^a   Song, Kyo Young ^a   Simpson, Guy ^b   Coffin, Robert ^b   Fong, Yuman ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Biovex Inc   (United States)

Author keywords

gastroesophageal cancer; herpesvirus; oncolytic

Indexed keywords

ONCOLYTIC VIRUS;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CYTOTOXICITY; DOSE RESPONSE; ESOPHAGEAL ADENOCARCINOMA; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; ONCOLYTIC VIROTHERAPY; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; STOMACH CANCER; VERO CELL; VIRUS REPLICATION; ESOPHAGEAL NEOPLASMS; GENETICS; PHYSIOLOGY; STOMACH NEOPLASMS; TUMOR CELL LINE; VIROLOGY;

CELL LINE, TUMOR; ESOPHAGEAL NEOPLASMS; HERPESVIRUS 1, HUMAN; HUMANS; ONCOLYTIC VIROTHERAPY; STOMACH NEOPLASMS; VIRUS REPLICATION;

EID: 77956933263     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2010.03.021     Document Type: Article

References (31)

1. S.R. Alberts, A. Cervantes, and C.J.H. van de Velde Gastric cancer: Epidemiology, pathology and treatment Ann Oncol 14 2003 ii31
2. H. Kasuya, S. Takeda, and S. Nomoto The potential of oncolytic virus therapy for pancreatic cancer Cancer Gene Ther 12 2005 725
3. M. Garcia, A. Jemal, and E.M. Ward Global Cancer facts and figures 2007 2007 American Cancer Society Atlanta, GA
4. Y. Yonemura, E. Bandou, and T. Kawamura Quantitative prognostic indicators of peritoneal dissemination of gastric cancer Eur J Surg Oncol 32 2006 602
5. S. Gretschel, R. Siegel, and L. Estevez-Schwarz Surgical Strategies for gastric cancer with synchronous peritoneal carcinomatosis Br J Surg 93 2006 1530
6. J.J. Bonenkamp, J. Hermans, and M. Sasako Extended lymph-node dissection for gastric cancer N Engl J Med 340 1999 908
7. H.H. Hartgrink, C.J.H. van de Velde, and H. Putter Extended lymph node dissection for gastric cancer: Who may benefit? Final results of the randomized Dutch gastric cancer group trial J Clin Oncol 22 2004 2069
8. F.A. Khan, and A.N. Shukla Pathogenesis and treatment of gastric carcinoma: An up-date with brief review J Cancer Res Ther 2 2006 196
9. M. Ohashi, H. Ueno, and T. Tanaka Adenovirus mediated p53 tumor suppressor gene therapy for human gastric cells in vitro and in vivo Gut 44 1999 366
10. T.J. Song, D.P. Eisenberg, and P.S. Adusumilli Oncolytic herpes viral therapy is effective in the treatment of hepatocellular carcinoma cell lines J Gastrointestinal Surg 10 2006 532
11. V. Reid, Z. Yu, and T. Schuman Herpes oncolytic therapy of salivary gland tumors Int J Cancer 122 2007 202
12. N. Kemeny, K. Brown, and A. Covey Phase I, open-label, dose-escalating study of a genetically engineered herpes simplex virus, NV1020, in subjects with metastatic colorectal carcinoma to the liver Human Gene Ther 17 2006 1214
13. B. Roizman The function of herpes simplex virus genes: A primer for genetic engineering of novel vectors Proc Natl Acad Sci USA 93 1996 11307
14. B. Everts, and H.G. Van der Poel Replication-selective oncolytic viruses in the treatment of cancer Cancer Gene Ther 12 2005 141
15. B.L. Liu, M. Robinson, and Z.-Q. Han ICP34.5 deleted herpes simplex virus with enhanced in colitic, immune stimulating, and anti-tumor properties Gene Ther 10 2003 292
16. S. Varghese, and S. Rabkin Oncolytic herpes simplex virus vectors for cancer virotherapy Cancer Gene Ther 9 2002 967
17. J.J. Bennett, D.A. Kooby, and K. Delman Antitumor efficacy of regional oncolytic viral therapy for peritoneally disseminated cancer J Mol Med 78 2000 166
18. J.J. Bennett, K.A. Delman, and B. Burt Comparison of safety, delivery, and efficacy of two oncolytic herpes viruses (G207 and NV1020) for peritoneal cancer Cancer Gene Ther 9 2002 935
19. S.F. Stanziale, B.M. Stiles, and A. Bhargava Oncolytic herpes simplex virus-1 mutant expressing green fluorescent protein can detect and treat peritoneal cancer Human Gene Ther 15 2004 609
20. H.L. Kaufman, D.W. Kim, and G. Deraffele Local and distant immunity induced by intralesional vaccination with an oncolytic herpes virus encoding GM-CSF in patients with stage IIIc and IV melanoma Ann Surg Oncol 17 2009 718
21. Y. Fong, T. Kim, and A. Bhargava A herpes oncolytic virus can be delivered via the vasculature to produce biologic changes in human colorectal cancer Mol Ther 17 2009 389
22. G.R. Simpson, Z. Han, and Y. Wang Combination of a fusogenic glycoprotein, prodrug activation, and oncolytic herpes simplex virus for enhanced local tumor control Cancer Res 66 2006 4835
23. X. Fu, L. Tao, and A. Jin Expression of a fusogenic membrane glycoprotein by an oncolytic herpes simplex virus potentiates the viral antitumor effect Mol Ther 7 2003 748
24. Y. Hippo, M. Yashiro, and M. Ishii Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes Cancer Res 61 2001 889
25. J. Ji, X. Chen, and S.Y. Leung Comprehensive analysis of the gene expression profiles in human gastric cancer cell lines Oncogene 21 2002 6549
26. C.J. Yen, J.G. Izzo, and D.F. Lee Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma Cancer Res 68 2008 2632
27. H. Yokozaki Molecular characteristics of eight gastric cancer cell lines established in Japan Pathol Int 50 2000 767
28. Y. Mitsuhashi, M. Inaba, and Y. Sugiyama In vitro measurement of chemosensitivity of human small cell lung and gastric cancer cell lines toward cell cycle phase-nonspecific agents under the clinically equivalent area under the curve Cancer 70 2006 2540
29. N. Altorki, G.K. Schwartz, and M. Blundell Characterization of cell lines established from human gastric-esophageal adenocarcinomas biologic phenotype and invasion potential Cancer 72 1993 649
30. R.H. Feng, Z.G. Zhu, and J.F. Li Inhibition of human telomerase in MKN-45 cell line by antisense hTR expression vector induces cell apoptosis and growth arrest World J Gastroenterol 8 2002 436
31. K. Nakamura, M. Yashiro, and T. Matsuoka A novel molecular targeting compound as K-samII/FGF-R2 phosphorylation inhibitor, Ki23057, for scirrhous gastric cancer Gastroenterology 131 2006 1530